Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$1.27 - $8.17 $88,900 - $571,900
-70,000 Closed
0 $0
Q2 2021

Aug 30, 2021

SELL
$6.55 - $8.98 $458,500 - $628,600
-70,000 Reduced 50.0%
70,000 $531,000
Q2 2021

Aug 13, 2021

BUY
$6.55 - $8.98 $294,750 - $404,100
45,000 Added 47.37%
140,000 $1.06 Million
Q1 2021

May 10, 2021

BUY
$6.1 - $7.69 $579,500 - $730,550
95,000 New
95,000 $629,000

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $815M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Integral Health Asset Management, LLC Portfolio

Follow Integral Health Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integral Health Asset Management, LLC with notifications on news.